P1: GCP/GCZ P2: GCP/GCZ QC:
Psychiatric Quarterly [psaq] ph129-psaq-375279 September 18, 2002 16:9 Style ﬁle version June 4th, 2002
Psychiatric Quarterly, Vol. 73, No. 4, Winter 2002 (
NEW DIRECTIONS IN THE
POSTTRAUMATIC STRESS DISORDER
Charles R. Marmar, M.D., Thomas C. Neylan, M.D.,
and Frank B. Schoenfeld, M.D.
Advances in psychopharmacology of PTSD are presented, focusing on antide-
pressants, adrenergic agents, antianxiety agents, and mood stabilizers. Treat-
ment recommendations are related to recent advances in the understanding of
the biology of PTSD. Pharmacotherapy of PTSD in children and adolescents is
discussed, including recommended dose ranges. Recommendations are speci-
ﬁed for pharmacotherapy of trauma survivors in the immediate aftermath of
traumatic exposure, and for those with acute and chronic posttraumatic stress
KEY WORDS: psychopharmacology for PTSD; new directions.
All authors are afﬁliated with Department of Psychiatry, University of California, San
Francisco, California, and Department of Veterans Affairs Medical Center, San Francisco,
Address correspondence to Charles R. Marmar, M.D., DVA Medical Center, 4150
Clement St. 116A, San Francisco, CA 94121; e-mail: email@example.com.
2002 Human Sciences Press, Inc.